JPRN-UMIN000036469招募中未知
Efficacy and Safety of Sequential Sublingual Immunotherapy with Japanese Ceder Pollen and House Dust Mite allergens - Efficacy and Safety of Sequential SLIT with JCP and HDM
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 184
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 5years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who can not obtain written research cooperation. Patients who can not confirm their own consent to participate in research. Patients who are judged not to participate in this study by their doctor
研究者
相似试验
已完成
3 期
Clinical efficacy and safety of sublingual immunotherapy in patients with Japanese cedar pollinosis.A double-blind,placebo-controlled study.Japanese cedar pollinosisJPRN-UMIN000000709Department of Otorhinolaryngology in Ciba University Graduate School150
进行中（未招募）
不适用
Efficacy and Safety of Sublingual Immunotherapy with Ultra-Rush Titration in Children with Allergic Rhinoconjunctivitis to Tree Pollen, a Multicentre DBPC Trial - SLIT Efficacy ChildreAllergic rhinitis against birch pollenEUCTR2004-002350-63-DEStallergenes GmbH & Co.KG240
进行中（未招募）
不适用
A study, which aims to evaluate the efficacy and safety of LAIS® Birch-Alder tablets in patients suffering from allergic inflammation of the conjunctiva and rhinitis caused by birch pollePatients suffering from allergic rhinoconjunctivitisMedDRA version: 17.1Level: LLTClassification code 10001728Term: Allergic rhinoconjunctivitisSystem Organ Class: 100000004853EUCTR2013-002129-43-DEofarma S.p.A.
进行中（未招募）
1 期
Efficacy and Safety of sublingual immunotherapy with Allergoid LAIS Birch tablets for patients with tree pollen-induced allergic rhinoconjunctivitis with or without mild controlled asthmaEUCTR2018-002596-18-ITOFARMA S.P.A.110
进行中（未招募）
1 期
A study which aims at evaluating the efficacy and safety of LAIS® Grass tablets in patients suffering from g from allergic inflammation of the conjunctiva and rhinitis which are caused by grass pollePatients suffering from allergic rhinoconjunctivitisMedDRA version: 16.1Level: LLTClassification code 10001728Term: Allergic rhinoconjunctivitisSystem Organ Class: 100000004853EUCTR2012-004916-79-DEofarma S.p.A.200